SOLACI-CACI 2024 – Day 1 Presentations

Discover the highlights of the first day of activities of SOLACICACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. 

  • Dr. Mauricio Cohen (USA) – “How to start a CHIP program?”
  • Dr. Augusto Pichard (USA) – “Current Strategies for Percutaneous Treatment of SVG Disease in ACS”
  • Dra. Alaide Chieffo (ITA) – “Analysis of post-stent coronary dissections, when we should treat it”
  • Dr. George Dangas (USA) – “Is there a role for thrombus aspiration in PCI?”
  • Dr. Roxana Mehran (USA) – “Anti-platelet treatment in AMI and Inflammation”
  • Dr. Daniel Berrocal (ARG) – “PCI in Patient with Symptomatic Chronic Coronary Syndrome”
  • Dr. Daniel Aguirre (CHL) – “Required Credentials for an Interventional Cardiologist to Intervene in Adult Congenital Heart Disease”
  • Dra. Tieta Albanez (BRA) – “Current Status of LMCA PCI: Contributions From Clinical Studies”
  • Dr. Mario Araya (CHL) – “Dissections: what we should and should not leave”
  • Dr. Ricardo Costa (BRA) – “Understand the concepts, techniques, and devices to achieve optimal vessel preparation for the perfect DEB outcome-DEB technology in de novo coronary lesions”
  • Dr. Juan Ignacio Damonte (ARG) – “Barriers and oportunities in the decision -making process for a Cardiology subespeciality”
  • Dr. Anibal Damonte (ARG) – “LAAO: What´ s the best management of peridevice leak?”
  • Dr. George Dangas (USA) – “TAVR and Coronary artery disease”
  • Dr. Diego Guzzanti (ARG) – “Deep Vein Thrombosis: Treatment. Pharmacoinvasive Treatment and Percutaneous Thrombectomy”
  • Dr. Pablo Mascolo (ARG) – “When do we consider a lesion to be non-obstructive: by angiography or angioCT”
  • Dr. Ricardo Lluberas (UY) – “Multivessel Disease: Is Complete Revascularization Necessary in Fragile Adult Patients?”
  • Dr. José Martín Rabellino (ARG) – “Surgery for TAVI failure: what do we know about device explantation?”
  • Dr. Evandro Martins (BRA) – “The post-CABG CTO challenge”
  • Dr. Matías Rodríguez Granillo (ARG) – “Patient with Coronary Disease and Diabetes”
  • Dr. Sebastián Mrad (ARG) – “Mentoring as a Tool to Optimize Decision-Making During a Medical Career”

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

New Virtual Event from CHIP LATAM SOLACI: Mexico Chapter

The Latin American Society of Interventional Cardiology invites you to participate in a new educational activity organized by the Department of Complex Percutaneous Coronary...

Miami Valves 2025

Between January 30 and February 1, 2025, the Miami Valves 2025 will take place in Miami, Florida, USA, at the Miami Marriott Biscayne Bay...

January 23 – SOLACI Medtronic Webinar: Visualizing Different PCI Techniques for Bifurcations from a Totally Different Perspective

A new virtual educational event is coming, organized by the Latin American Society of Interventional Cardiology with the support of Medtronic. This time, we will...

Cuba Sessions 2025 | Young Interventional Cardiologists Contest

Call for Case Submission L SOLACI Regional Sessions - 18° Central America & The Caribbean Region - It is with great pleasure that we hereby...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Timing in Complete Revascularization in Acute Coronary Syndrome: BIOVASC 2-Year Followup

The concept of complete revascularization (CR) has been comprehensively studied, leading to diverse approaches and debates on optimal timing.  The BIOVASC trial explored the ideal...

DCB-BIF Trial: Randomized Study of Side Branch Drug-Coated Balloon Angioplasty Following Provisional Stenting

Coronary bifurcations present technical challenges that should be addressed for adequate coronary geometry. The first treatment option for complex coronary bifurcations (according to the...

Coronary Sinus Reducer for Refractory Angina: Notes from the REDUCER-I Study

Refractory angina is defined as the presence of ischemic symptoms that cannot be controlled through optimal medical therapy (OMT) or interventional treatment. Patients who...